Search Within

Department of Medicine

Formats
  1. Journal Article (19620)
  2. Meeting Abstract (16084)
  3. Review (1158)
  4. Book Section (934)
  5. Editorial (611)
  6. Research Letter (316)
  7. Conference Paper (301)
  8. Guidelines (298)
  9. Correspondence (237)
  10. Miscellaneous (91)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22367)
  2. Hematologic Malignancies, Division of (13308)
  3. Center for Hematologic Malignancies (11082)
  4. GSK Faculty (10658)
  5. Survivorship Research (9352)
  6. Division of Subspecialty Medicine (7560)

More Groups

People
  1. Robert Motzer (1251)
  2. Howard Scher (1133)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (906)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1158)
  2. 2024 (2293)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1411)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (904)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2898)
  5. Oxford University Press (2304)
  6. Nature Publishing Group (2122)

More Publishers

Results (39711)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular features and outcomes for patients receiving elranatamab for relapsed or refractory multiple myeloma in MagnetisMM-1
    Meeting Abstract

    Tomasson, M. H.; Bahlis, N. J.; Costello, C.; Raje, N. S.; Levy, M. Y.; Dholaria, B. R.; Solh, M. M.; Damore, M. A.; Jiang, S.; Xie, T.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Belantamab mafodotin (belamaf) for relapsed/refractory multiple myeloma (RRMM): A real-world observational study update
    Meeting Abstract

    Hultcrantz, M.; Kleinman, D.; Vij, R.; Escalante, F.; Delforge, M.; Kotowsky, N.; Bitetti, J.; Boytsov, N.; Camadoo-O'Byrne, L.; Powers Happ, L.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Patterns, perceptions, and experience with cannabidiol (CBD) after cancer diagnosis
    Meeting Abstract

    Lapen, K.; Mao, J. J.; Raghunathan, N. J.; Jinna, S.; Brens, J.; Hernandez, M.; Korenstein, D.; Salz, T.; Chino, F.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase Ib/II study of intermittent talazoparib plus temozolomide in patients with metastatic castration-resistant prostate cancer (mCRPC) and no mutations in DNA damage repair (DDR)
    Meeting Abstract

    Autio, K. A.; Kyriakopoulos, C.; Xiao, H.; Emamekhoo, H.; Danila, D. C.; Devitt, M. E.; Riedel, E.; Jan, M.; Scher, H. I.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • 3D genomics identify alternate mechanisms of homologous recombination deficiency in uterine sarcoma
    Meeting Abstract

    Chiang, S.; Hensley, M. L.; Vasudevaraja, V.; Tran, I.; Yang, Y.; Stewart, C. J. R.; Park, K. J.; Ellenson, L. H.; Sikkink, K.; Schmitt, A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Enhancing patient clinical streamlining (EPACS) pilot in the breast medicine service at Memorial Sloan Kettering Cancer Center
    Meeting Abstract

    Amel Riazat-Kesh, Y. J. R.; Miceli, M. R.; Smith, A.; Keenan, K.; Morrison, J.; Magnoli, R.; Strong, V. E.; Traina, T. A.; Sanford, R. A.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Real-world utilization pattern of pexidartinib in patients with tenosynovial giant cell tumor (TGCT)
    Meeting Abstract

    Lin, F.; Tse, J.; Shaikh, N. F.; Wang, E. J.; Near, A.; Kwong, J.; Tap, W. D.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Ustekinumab for the treatment of immune related cutaneous adverse events (ircAEs)
    Meeting Abstract

    Maier, T.; Gu, S.; Shah, N. J.; Faleck, D. M.; Lacouture, M. E.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Negative selection of patients (pts) with HER2-positive and RAS wild-type (wt) metastatic colorectal cancer (mCRC) receiving dual HER2 blockade
    Meeting Abstract

    Randon, G.; Nakamura, Y.; Yaeger, R.; Lonardi, S.; Cremolini, C.; Elez, E.; Nichetti, F.; Ghelardi, F.; Nasca, V.; Bergamo, F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Predictors of resistance to trastuzumab deruxtecan (T-DXd) in esophagogastric adenocarcinoma (EGC)
    Meeting Abstract

    Tsai, C.; Chou, J. F.; Biachi de Castria, T.; Tang, L. H.; Ilson, D. H.; Ku, G. Y.; Schultz, N.; Capanu, M.; Janjigian, Y. Y.; Maron, S. B.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save